Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: A Korean Lung Cancer Registry Study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | In, Kwang-Ho | - |
dc.contributor.author | Kwon, Yong-Soo | - |
dc.contributor.author | Oh, In-Jae | - |
dc.contributor.author | Kim, Kyu-Sik | - |
dc.contributor.author | Jung, Maan-Hong | - |
dc.contributor.author | Lee, Kwan-Ho | - |
dc.contributor.author | Kim, Sun-Young | - |
dc.contributor.author | Ryu, Jeong-Seon | - |
dc.contributor.author | Lee, Sung-Yong | - |
dc.contributor.author | Jeong, Eun-Taik | - |
dc.contributor.author | Lee, Sang-Yeub | - |
dc.contributor.author | Yum, Ho-Kee | - |
dc.contributor.author | Lee, Chang-Geol | - |
dc.contributor.author | Kim, Woo-Sung | - |
dc.contributor.author | Zo, Jae-Ill | - |
dc.contributor.author | Kim, Hojoong | - |
dc.contributor.author | Kim, Young-Whan | - |
dc.contributor.author | Kim, Se-Kyu | - |
dc.contributor.author | Lee, Jae-Cheol | - |
dc.contributor.author | Kim, Young-Chul | - |
dc.date.accessioned | 2021-09-08T17:39:46Z | - |
dc.date.available | 2021-09-08T17:39:46Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2009-05 | - |
dc.identifier.issn | 0169-5002 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/120158 | - |
dc.description.abstract | Purpose and methods: The outcomes of lung cancer patients who were asymptomatic at diagnosis have never been reported as part of a large-scale study. A national survey of lung cancer in South Korea registered a total of 8788 patients diagnosed in 2005. We report the results herein, with an emphasis on the prognosis of the asymptomatic lung cancer patients. Results: Adenocarcinoma was the most frequent (36.1%) histopathologic type, followed by squamous cell carcinoma (32.1%), large cell carcinoma (1.5%), and small cell carcinoma (13.5%). In most cases, lung cancer was detected with subjective symptoms, but 6.5% of cases had no symptoms indicative of lung cancer at the time of diagnosis. Compared to symptomatic patients, asymptomatic patients were younger, more often female, non-smokers, and more frequently presented with adenocarcinoma. Initial treatments were surgery (22.1%), radiation therapy (7.8%), chemo-radiation therapy (5.4%), and chemotherapy (38%), while 26.6% of patients were recorded to have supportive care only. Asymptomatic patients received surgery in 60.0% of cases, and they showed significantly longer survival times than symptomatic patients. Absence of symptoms at diagnosis significantly reduced the risk of death from non-small cell lung cancer, regardless of patient age, patient gender, stage at diagnosis, smoking history, or whether treatment was performed, but did not reduce the risk of death from small cell lung cancer. Conclusions: Adenocarcinoma has grown to be the leading histopathologic type of lung cancer in South Korea. Absence of symptom at diagnosis is a favorable prognostic factor for patients with non-small cell lung cancer. (C) 2008 Elsevier Ireland Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.subject | SURVIVAL | - |
dc.subject | GEFITINIB | - |
dc.title | Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: A Korean Lung Cancer Registry Study | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | In, Kwang-Ho | - |
dc.contributor.affiliatedAuthor | Lee, Sang-Yeub | - |
dc.identifier.doi | 10.1016/j.lungcan.2008.08.005 | - |
dc.identifier.scopusid | 2-s2.0-63049110662 | - |
dc.identifier.wosid | 000265996600016 | - |
dc.identifier.bibliographicCitation | LUNG CANCER, v.64, no.2, pp.232 - 237 | - |
dc.relation.isPartOf | LUNG CANCER | - |
dc.citation.title | LUNG CANCER | - |
dc.citation.volume | 64 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 232 | - |
dc.citation.endPage | 237 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Respiratory System | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Respiratory System | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | GEFITINIB | - |
dc.subject.keywordAuthor | Lung neoplasms | - |
dc.subject.keywordAuthor | Registries | - |
dc.subject.keywordAuthor | Epidemiology | - |
dc.subject.keywordAuthor | Survival | - |
dc.subject.keywordAuthor | Korea | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.